Clinical trial

Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination

NCT01627938

Study summary

ClinicalTrials.gov

Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Dexrazoxane (DRZ) plus Mitoxantrone (MX) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo plus Mitoxantrone (MX) Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2012-04-01

PhasePHASE2

Conditions

Multiple Sclerosisverified · MONDO: multiple sclerosis

Interventions

Dexrazoxane (DRZ) plus Mitoxantrone (MX)DRUG

Placebo plus Mitoxantrone (MX)DRUG

Sponsors & collaborators

PD Dr. Andrew Chanlead sponsor

Mapped research locations

BochumGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01627938 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.